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Aneuploidy causes a proliferative disadvantage in all
normal cells analyzed to date, yet this condition is
associatedwith a disease characterized by unabated
proliferative potential, cancer. The mechanisms that
allow cancer cells to tolerate the adverse effects of
aneuploidy are not known. To probe this question,
we identified aneuploid yeast strains with improved
proliferative abilities. Their molecular characteriza-
tion revealed strain-specific genetic alterations as
well asmutations sharedbetweendifferent aneuploid
strains. Among the latter, a loss-of-functionmutation
in the gene encoding the deubiquitinating enzyme
Ubp6 improves growth rates in four different aneu-
ploid yeast strains by attenuating the changes in
intracellular protein composition caused by aneu-
ploidy. Our results demonstrate the existence of
aneuploidy-tolerating mutations that improve the
fitnessofmultiple different aneuploidies andhighlight
the importanceof ubiquitin-proteasomal degradation
in suppressing the adverse effects of aneuploidy.
INTRODUCTION
Aneuploidy, defined as any chromosome number that is not a
multiple of the haploid complement, is associated with death
and severe developmental abnormalities in all organisms
analyzed to date (reviewed in Torres et al., 2008; Williams and
Amon, 2009). Aneuploidy is the leading cause of miscarriages
and mental retardation in humans and is found in 90% of human
cancers (Hassold and Jacobs, 1984; Holland and Cleveland,
2009). Despite the high incidence of aneuploidy in tumors, its
role in tumorigenesis remains uncertain (Holland and Cleveland,
2009; Schvartzman et al., 2010).
To shed light on the relationship between aneuploidy and
tumorigenesis, we previously determined the effects of aneu-
ploidy on normal cells. Twenty strains of budding yeast, eachbearing an extra copy of one or more of almost all of the yeast
chromosomes (henceforth disomic yeast strains), display
decreased fitness relative to wild-type cells and share traits
that are indicative of energy and proteotoxic stress: metabolic
alterations, increased sensitivity to conditions that interfere
with protein translation, folding, and turnover (Torres et al.,
2007), a cell proliferation defect (specifically a G1 delay), and
a gene expression signature known as the environmental stress
response (Gasch et al., 2000). These shared traits are due to the
additional gene products produced from the additional chromo-
somes. Primary aneuploid mouse cells exhibit similar pheno-
types (Williams et al., 2008). On the basis of these findings, we
proposed that aneuploidy leads to an ‘‘aneuploidy stress
response.’’ In this response, cells engage protein degradation
and folding pathways in an attempt to correct protein stoichiom-
etry imbalances caused by aneuploidy. This puts a significant
burden on these protein quality-control pathways, resulting in
increased sensitivity to compounds that interfere with protein
degradation and folding. Synthesis and neutralization of the
proteins produced from the additional chromosomes also lead
to an increased need for energy.
The increased sensitivity of many aneuploid yeast strains to
cycloheximide and proteasome inhibitors suggests that ubiqui-
tin-mediated protein degradation is one of the protein quality
control pathways as being affected in aneuploid cells. During
ubiquitin-mediated protein degradation, multiple ubiquitin
molecules are covalently linked to a substrate, which allows
recognition by the 26S proteasome (Varshavsky, 2005). Upon
recognition, ubiquitin chains are removed, and substrates are
fed into the catalytic cavity of the proteasome. Two deubiquiti-
nating enzymes, Rpn11 and Ubp6, remove ubiquitin from
substrates (Chernova et al., 2003; Hanna et al., 2003; Verma
et al., 2002; Yao and Cohen, 2002). Both of these proteases
are associated with the proteasome and are essential for ubiqui-
tin recycling. In the absence of either protein, levels of free
ubiquitin rapidly decline as a result of degradation of ubiquitin
chains by the proteasome. In addition to a role in ubiquitin recy-
cling, Ubp6 regulates proteasomal degradation. In its absence,
proteasomal degradation of several substrates is accelerated
(Hanna et al., 2006; Peth et al., 2009). The results describedCell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc. 71
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Figure 1. Evolution of Aneuploid Yeast
Strains
(A) Doubling times of disome V (open squares), dis-
ome VIII (open triangles), disome XI (open circles),
and wild-type cultures (open diamonds) were
measured at the indicated times. The arrows indi-
cate the generation when growth rates increased.
(B) Doubling times of wild-type cells (black bar),
parental disomes (red bars), and evolved isolates
(open bars) were determined in His+G418
medium at room temperature (n = 3, error bars
represent ± standard deviation [SD], *p value <
0.01, Student’s t test). Nomenclature: The Roman
numerals describe the identity of the disomic chro-
mosome. The number after the dash indicates
when the clone was isolated (after 9 or 14 days
of continuous growth), and the number after the
period describes the identity of the clone.
(C) Gene expression analysis of wild-type,
parental, and evolved disomic strains grown in
batch culture, ordered by chromosome position.
Experiments (columns) are ordered by the number
of the chromosome that is present in two copies.
Data were normalized to account for the extra
chromosome present in disomic strains. Upregu-
lated genes are shown in red and downregulated
ones in green.
See also Tables S1, S2, and S3 and Figures S1
and S2.here indicate that Ubp6, through its role in protein degradation
control, affects the proliferative abilities of several aneuploid
yeast strains.
The consequences of system-wide aneuploidy of only a single
chromosome are severe in all organisms analyzed to date
(reviewed in Torres et al., 2008). In striking contrast, in most
cancer cells, aneuploidy is common, typically involving many
chromosomes, but proliferation potential in these cells is high
(reviewed in Albertson et al., 2003). To resolve these contradic-
tory observations, we hypothesized that genetic alterations
must exist that allow cancer cells to tolerate the adverse effects
of aneuploidy. To test this idea, we isolated aneuploid yeast
strains with increased growth rates and characterized their
genetic alterations. This analysis revealed strain-specific genetic
changes and mutations shared between different aneuploid
strains. We characterized further one of these shared genetic
alterations, a loss-of-function allele in the gene encoding the
deubiquitinating enzyme Ubp6. Our studies show that inactiva-
tion of UBP6 improves the proliferation rates of four different
disomic yeast strains and suggest amechanism for this suppres-
sion. Deletion of UBP6 attenuates the effects of aneuploidy on
cellular protein composition. Our results demonstrate the
existence of aneuploidy-tolerating mechanisms. Enhanced
proteasomal degradation appears to be one of them.
RESULTS
Isolation of Aneuploid Yeast Strains
with Increased Proliferative Abilities
To identify genetic alterations that suppress the adverse effects
of specific aneuploidies or perhaps even multiple different
aneuploidies, we sought variants of 13 different disomic yeast72 Cell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc.strains that proliferate well despite the presence of a disomic
chromosome. To isolate variants of disomic yeast strains
with decreased doubling time, we used continuous growth
under conditions that select for the presence of the disomic
chromosome rather than a traditional mutagenesis approach
to keep the number of genetic alterations low (Experimental
Procedures).
Environmental conditions such as media composition greatly
influence the outcome of evolution experiments (Gresham
et al., 2008; Zeyl, 2006). Therefore, we initially chose two sets
of disomic yeast strains, one that required growth in medium
lacking uracil and histidine (UraHis medium) to select for
the presence of the extra chromosome, and another that
required growth in medium lacking histidine and containing the
antibiotic G418 (His+G418 medium). The doubling time of the
disomic yeast strains was significantly longer in His+G418
medium than in UraHis medium (data not shown). We
suspect that this is due to G418’s ability to cause frameshifts
during translation (Davies and Davis, 1968; Davies et al., 1964).
The increase in frameshifts further enhances the burden on the
protein quality-control pathways that help aneuploid cells deal
with the proteins produced from the additional chromosomes.
The greater difference in doubling time between wild-type
and aneuploid cells in His+G418 medium together with the
finding that some disomic strains (e.g., disome V) appeared
to lose large parts of the additional chromosome more readily
in UraHis medium (data not shown) prompted us to perform
the selection for disomic strains with increased proliferative rates
inHis+G418medium. Passaging of cells in this medium initially
led to an increase in doubling times in many strains (Figure 1A;
Table S1 available online). We do not yet understand the molec-
ular basis for this transient slowing of cell proliferation, but we
note that it is reminiscent of the crisis period observed during
serial passage of primary mammalian cells in culture (Todaro
and Green, 1963). Populations with decreased doubling times
emerged shortly thereafter (Table S1).
We isolated single colonies after 9 days (37–66 generations;
Table S1) and 14 days (64–105 generations; Table S1).
Doubling-time measurements confirmed that 11 out of 13
disomic yeast strains had produced clones with significantly
increased proliferation rates (Figure 1B) and changed the cell-
cycle distribution to be more similar to that of wild-type cells
(i.e., Figure S1A). We predicted that we would obtain two types
of suppressor mutations: mutations that improve the growth of
disomic yeast strains only in His+G418 medium in which the
cells are coping with the additive stresses of G418 and aneu-
ploidy and are therefore more sensitive to suppressor mutations
with milder effects, and mutations that improve proliferation irre-
spective of which medium cells are cultured in. This appeared to
be the case. All evolved isolates obtained from disomes IX, XI,
XIII, and XVI (the disomic strains whose proliferation is only mini-
mally affected in YEPD medium to begin with) showed fitness
gain only in His+G418 medium but not in YEPD (Figure S1B).
This phenomenon of genomic alterations being condition
specific has been observed previously (i.e., Dettman et al.,
2007). We conclude that aneuploidy-tolerating mutations exist
that are growth condition specific and that improve proliferation
more generally.
Evolved Isolates Obtained from Four Disomic Strains
Exhibit Gross Chromosomal Rearrangements
To determine the basis for the decrease in doubling time in the
evolved disomic strains, we first examined their karyotypes.
Comparative genome hybridization (CGH) analysis revealed
that the overall chromosomal composition was not altered in
the majority of disomic strains (Table S2). Thus, the improved
growth rates of these isolates must be caused by alterations
that are undetectable by CGH analysis.
Descendants of strains disomic for chromosome IV experi-
enced loss of the entire additional chromosome and most
diplodized (Table S2). Isolates obtained from strains disomic
for chromosome XII, XIV, or XV had lost large parts of one
copy of the duplicated chromosome but also carried a duplica-
tion of a region of the left arm of chromosome XIII (TEL13L–
YML046W; 183 kb, 345 genes; Table S2). It is highly likely that
loss of all or part of the chromosome present in two copies is
in large part responsible for the increase in proliferation rate
seen in the evolved strains, but we speculate that genes exist
in region TEL13L–YML046W, whose 2-fold increase in copy
number improves proliferation of three different disomic yeast
strains.
Truncations of the duplicated chromosome occurred in or next
to Ty elements, retrotransposons that are scattered throughout
the yeast genome. This correlation indicates that homologous
recombination between these repeated elements was respon-
sible for the loss of these regions. The ends of regions
TEL13L–YML046W were also at or near Ty elements. Given
that region TEL13L–YML046W does not carry a centromere
but is nevertheless stably inherited, it is highly likely that the
duplicated region TEL13L–YML046W represents a translocationcaused by Ty element-mediated recombination. Our results
indicate that cells carrying an extra chromosome rapidly evolve
and acquire genomic alterations. These include point mutations
(see below), truncations, amplifications, and whole-genome
duplications.
Expression of the Genes Encoded by the Duplicated
Chromosomes Is Not Attenuated in the Evolved Isolates
We showed previously that the majority of genes present on the
disomic chromosome are expressed according to gene copy
number exhibiting an average increase in gene expression of
approximately 1.82-fold (Torres et al., 2007). Downregulation of
gene expression of the disomic chromosome, like loss of large
parts of the additional chromosome, could lead to increased
proliferation rates. Gene expression analysis of the evolved
strains that retained both copies of the disomic chromosome
showed that gene expression of the chromosome present at
two copies was not attenuated even though proliferation rates
were increased (Figure 1C). Average expression of genes
present on the disomic chromosome was increased an average
of 1.84-fold compared to the rest of the genome. Thus, attenua-
tion of gene expression of the disomic chromosome is not
responsible for the improved proliferation rates.
Our previous analysis of the disomic strains revealed a
transcription profile shared by different disomes (Torres et al.,
2007). This aneuploidy signature was only seen under conditions
that eliminated the differences in growth rate between aneuploid
strains (cells were grown in the chemostat under phosphate-
limiting conditions). Gene expression analysis of the evolved
isolates grown under these conditions confirmed that global
gene expression patterns were maintained, with each evolved
strain clustering most closely with its parental disomic strain
(Figure S2A). Interestingly, the gene expression patterns of
the two evolved disomic strains that we analyzed were more
similar to each other than to the parental disomic strain
(Figure S2A). This result suggests that the genetic alterations in
the different isolates affect the same pathways and lead to a
similar transcriptional response in the evolved strains.
To determine whether the evolved strains share a transcrip-
tional profile that is distinct from that shared by the parental
strains, we subtracted the original disome expression values
from that of the evolved strains. This analysis revealed a common
expression pattern among the evolved strains (Figure S2; Table
S3). Ion transport, especially iron, and a subset of ribosomal
proteins were significantly enriched in the decreased expression
cluster (Table S3). Genes with increased expression were
enriched for genes involved in amino acid metabolism (p value =
9.69 3 1020). This group includes many of the genes respon-
sible for biosynthesis of aromatic amino acids, branched chain
amino acids, and arginine (Table S3). The significance of this
expression signature is at present unclear, but we speculate
that increased protein synthesis as a result of the presence of
an additional chromosome (see below) may bring about the
need for increasing production of amino acids. Strain-specific
expression changes also occurred. For example, a small group
of genes increased in expression in both isolates from disome
IX (Figure S2B). However, these gene groupings were rarely
enriched for particular classes of genes, although they may beCell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc. 73
more informative when combined with knowledge of the muta-
tions carried by these strains. We conclude that descendants
of disomic strains with improved growth share a gene expression
signature.
Identification of Point Mutations Associated with
Increased Proliferation Rates in Aneuploid Yeast Cells
Evolved aneuploid strains that proliferate faster yet have main-
tained both copies of the disomic chromosome probably harbor
heritable alterations not detectable by CGH. We selected 14
strains in which to identify these genetic alterations because
their proliferation rates were significantly improved compared
to the parent strain (Figure 1B). Tiling arrays or deep sequencing
identified 43 single-nucleotide polymorphisms (SNPs) that led to
nonsynonymous changes (Table 1) and four SNPs that led to
synonymous genetic alterations that were verified by Sanger
sequencing (Table S4, part A). In two evolved isolates of disome
XIII, we could not detect any nonsynonymous genetic changes.
A 1 base pair deletion, ten synonymous alterations, and 21
nonsynonymous alterations were present in the parental disomic
strains (Table S4, part B). We note that the mutations already
present in the parental disomic strains were probably acquired
during their construction and could also confer a growth
advantage.
Each evolved strain contained between two and seven SNPs,
and little overlap was detected among descendants from the
same parent strain (Table 1), indicating that different alterations
lead to improved proliferation in the different disomic strains.
Identical point mutations were only isolated among different
descendants of disomes XI and XIV, indicating that a selective
sweep had not occurred in the evolution experiments. Interest-
ingly, all three evolved disome XVI strains contained unique
mutations in the poorly characterized SVF1 gene (Table 1). The
emergence of mutations in this gene in three independent
isolates of disome XVI with improved growth properties
suggests that inactivation or hyperactivation of this factor (we
do not know how the identified point mutations affect SVF1
function) confers a selective advantage on strains disomic for
chromosome XVI.
Mutations in two genes were identified in descendants of
different disomes. Point mutations in the gene encoding the
vacuolar-targeting factor Vsp64 were identified in descendants
of disome IX and XI (Table 1). Mutations (premature stop codons)
in the gene encoding the deubiquitinating enzyme Ubp6 were
identified in descendants of disome V and IX. This finding raises
the interesting possibility that mutations exist that improve
growth rates of more than one disome.
Genes involved in chromatin remodeling, stress response, and
protein folding, as well as ribosomal RNA (rRNA) processing,
were among those mutated in the evolved disomic strains and
could contribute to the improved proliferative abilities of the
evolved disomic strains. Striking, however, was the fact that
fast growing descendants of strains disomic for chromosomes
V, VIII, IX, XI, and XIV harbored mutations in genes encoding
proteins involved in proteasomal degradation (UBP6, RPT1,
RSP5, UBR1). These results suggest that changes in protein
degradation lead to an improvement in fitness in multiple
aneuploid yeast strains.74 Cell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc.Loss of UBP6 Function Suppresses the Proliferation
Defect of Several Disomic Yeast Strains
We decided to test whether a causal relationship exists between
mutations in UBP6 and improved proliferation rates of the
evolved strains, because sequence analysis identified prema-
ture stop codons in UBP6 in two different evolved disomic
strains. Ubp6 contains an ubiquitin-like (UBL) domain in its N
terminus that mediates binding to the proteasome and a pepti-
dase domain in the C-terminal half of the protein (Figure 2A).
Strain Dis V-14.1 carries a nonsense mutation resulting in the
conversion of glutamic acid 256 to a stop codon (ubp6E256X;
Figure 2A). Strain Dis IX-14.1 harbors an UBP6 allele that carries
a premature stop codon at position 404 (Figure 2A). Both muta-
tions leave the UBL domain of the protein intact but cause
enough of a truncation to inactivate Ubp6’s protease activity.
To determine whether the expression of this truncated version
of UBP6 was at least in part responsible for the decrease in
generation time of strains Dis V-14.1 and Dis IX-14.1, we
analyzed disome V cells carrying the ubp6E256X mutation.
To assess the effects of this mutation on fitness, we performed
a competition assay. In this assay, strains disomic for chromo-
some V carrying a GFP-PGK1 fusion integrated at URA3
were cocultured with disome V cells carrying the ubp6E256X
mutation also marked with URA3. We then monitored the
fraction of GFP positive cells in the cultures over time by flow
cytometry. Control experiments showed that, with the exception
of strains disomic for chromosome XIV, the GFP-PGK1 fusion
did not affect the proliferation rate of the different disomic strains
(data not shown).
Disome V cells carrying the ubp6E256X mutation proliferated
significantly better than disome V cells wild-type for UBP6
(Figure 2B; Figure S3). A truncation mutation in UBP6 was also
identified in disome IX strains with improved proliferative
abilities. In this strain too, replacement of the UBP6 locus with
the ubp6E256X allele led to an increase in fitness (Figure 2B;
Figure S3). Remarkably, the same allele also led to an increase
in proliferation rates in strains disomic for chromosome VIII and
XI (Figure 2B). The ubp6E256X allele did not improve the prolifer-
ative abilities of wild-type cells or of five other disomes (disome I,
XII, XIII, XV, XVI) that we analyzed (Figure S3) and had adverse
effects only in disome II and disome XIV cells (Figure 2B;
Figure S3). Deletion of UBP6 had similar effects on disomic
strains as expression of the UBP6 truncation. An increase in
fitness was observed in coculturing assays and in doubling-
time measurements (Figures 2C and 2D; Figure S4; data not
shown). Analysis of cell-cycle progression of disome V and dis-
ome XI cells lacking UBP6 revealed that the deletion suppresses
the G1 delay of these two disomic strains (Figure S1A). Finally,
we found that inactivation of UBP6 led to an increase in fitness
of strains disomic for chromosome XI, and V in YEPD medium
but not of strains disomic for chromosome VIII or IX (Figure 2E).
We conclude that inactivation of UBP6 improves the growth
rates of four different disomic strains in the presence of the
translation inhibitor and proteotoxic compound G418. In two
disomic strains, growth improvement was also seen in the
absence of the drug. Inactivation of UBP6 did not significantly
influence the growth of otherwise wild-type cells in YEPD
(Figure 2E) or His+G418 (Figure 2C; Figures S3 and S4).
Table 1. Nonsynonymous Genetic Changes in the Evolved Disomic Strains
Straina Gene Mutation Methodb Protein Function
Dis V-14.1 SNT1 L431R S, T Subunit of the Set3C deacetylase complex
Dis V-14.1 RAD3 (het) D148N S, T 50 to 30 DNA helicase, involved in nucleotide excision repair
Dis V-14.1 UBP6c E256X S, T Ubiquitin-specific protease
Dis V-14.1 DYN1 L526R S Cytoplasmic dynein heavy chain
Dis V-14.1 TSL1 N127D S Subunit of trehalose 6-phosphate synthase
Dis V-14.1 Chr X, 31906 C to G S, T Intergenic region
Dis V-14.1 Chr XIII, 442441 A to C S, T Intergenic region
Dis VIII-14.1 RPT1 Q281K T ATPase part of the 19S regulatory particle of the proteasome
Dis VIII-14.1 Chr V, 140399 C to G T Intergenic region
Dis IX-14.1 VPS64c Q23X T Vacuole targeting factor
Dis IX-14.1 UBP6c E404X T Ubiquitin-specific protease
Dis XI-9.1 VPS64c E103G S Vacuole targeting factor
Dis XI-9.1 SRC1 I721V S Inner nuclear membrane protein
Dis XI-9.1 Chr IX, 338123 C to T S Intergenic region
Dis XI-9.1 Chr XIII, 818616 G to T S Intergenic region
Dis XI-9.2 SAS10 G311V S Subunit of processome complex
Dis XI-9.2 RSP5d V591M S, T Ubiquitin-protein ligase
Dis XI-9.2 Chr IX, 183614d G to A S, T Intergenic region
Dis XI-14.1 RSP5d V591M S, T Ubiquitin-protein ligase
Dis XI-14.1 Chr IX, 183614d G to A S, T Intergenic region
Dis XIV-9.1 YGR266W D450Y S Protein of unknown function
Dis XIV-9.1 Chr VII, 827547 C to T S Intergenic region
Dis XIV-9.1 LAG2d D644E S Protein involved in determining longevity
Dis XIV-9.1 YNL234Wd D16N S Heme-binding protein involved in glucose signaling
Dis XIV-9.1 Chr XIV, 623023d C to S S Intergenic region
Dis XIV-9.2 UBR1 F951C S Ubiquitin-protein ligase
Dis XIV-9.2 DCS2 H269Y S Stress induced protein
Dis XIV-9.2 CCT7 P114R S Subunit of the chaperonin Cct ring complex
Dis XIV-9.2 Chr XIV, 148095 A to W S Intergenic region
Dis XIV-9.2 LAG2d D644E S Protein involved in determining of longevity
Dis XIV-9.2 YNL234Wd D16N S Heme-binding protein involved in glucose signaling
Dis XIV-9.2 Chr XIV, 623023d C to S S Intergenic region
Dis XIV-14.2 PRR2 E260X T Serine/threonine protein kinase
Dis XIV-14.2 BUD9 E499D T Protein involved in bud-site selection
Dis XIV-14.2 Chr XVI, 572683 C to G T Intergenic region
Dis XVI-9.1 SAS3 S689R S Histone acetyltransferase catalytic subunit of NuA3 complex
Dis XVI-9.1 SVF1e W178X S Protein with a potential role in cell survival pathways
Dis XVI-14.1 SEC31 S1116T S Essential component of the COPII coat of secretory pathway vesicles
Dis XVI-14.1 UTP10 P173S S Subunit of processome complex involved in production of 18S rRNA
Dis XVI-14.1 SVF1e A320P S Protein with a potential role in cell survival pathways
Dis XVI-14.2 GRX4 F188L S Glutathione-dependent oxidoreductase
Dis XVI-14.2 SVF1e E220X S Protein with a potential role in cell survival pathways
Dis XVI-14.2 Chr I, 71729 T to C S Intergenic region
a 9.1 and 9.2 refer to isolates 1 and 2 from day 9, respectively. 14.1 and 14.2 refer to isolates 1 and 2 from day 14, respectively.
b S, solexa sequencing; T, tiling arrays.
c This gene is mutated in descendants of different disomes.
d This mutation is present in more than one isolate.
e Three different mutations of SVF1 are present in three isolates of disome XVI.
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Figure 2. Loss of UBP6 Function Increases the Fitness of Strains Disomic for Chromosome V, VIII, IX, or XI
(A) Schematic of the Ubp6 domain structure. The N terminus contains an ubiquitin-like domain (UBL, amino acids 1–83), and the C terminus harbors the ubiquitin
hydrolase domain (amino acids 83–499). The positions of the catalytic cysteine 118 and the two early stop codons at positions 256 and 404 identified in evolved
disome V-14.1 and disome IX-14.1, respectively, are shown.
(B) The percentage of cells in cocultures of strains carrying PGK1 fused to GFP (open squares) and strains harboring a C-terminal truncated version of ubp6
(E256X, closed triangles) was determined at the indicated times. All strains were grown in His+G418 medium.
(C) The percentage of cells in cocultures of strains carrying PGK1 fused to GFP (open squares) and strains harboring a UBP6 deletion (ubp6D, closed triangles)
was determined at the indicated times. All strains were grown in His+G418 medium.
(D) Doubling times of the WT, disome V, evolved disome V-14.1, and disome V ubp6D strains grown in His+G418 medium (n = 3, error bars represent ± SD).
(E) Doubling times of theWT, disome V, disome VIII, disome IX and disomeXI strains either wild-type forUBP6 or carrying aUBP6 deletion grown in YEPDmedium
(n = 3, error bars represent ± SD; *p value < 0.01, Student’s t test).
See also Figures S3, S4, and S5.Next, we wished to determine the degree to which loss of
UBP6 function contributes to the increased fitness of evolved
Dis V-14.1 cells. We compared the doubling times of evolved76 Cell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc.Dis V-14.1 cells with that of disome V cells deleted for UBP6.
Deletion of UBP6 did not affect cell-cycle progression or
doubling time in wild-type cells (Figure S1A). However, it led to
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Figure 3. Ubiquitin Depletion Is Not
Responsible for the Aneuploidy Tolerance
Caused by Loss of UBP6 Function
(A) Wild-type, ubp6D, disome V, and disome V
ubp6D cells were grown in His+G418 medium
to an OD600 of 1.0 when 100 mg/ml cycloheximide
(time = 0 min) was added. Free ubiquitin and ubiq-
uitin conjugates were analyzed by immunoblotting
with an anti-ubiquitin antibody at the indicated
times.
(B) Ubiquitin levels in the presence (+) or absence
() of 100 mg/ml CuSO4.
(C– H) The percentage of cells in cocultures of
strains carrying PGK1 fused to GFP (open
squares) and strains harboring a UBP6 deletion
(closed triangles) was determined at the indicated
times. All strains carry a CUP1-UBI4 multicopy
plasmid whose expression was induced with
100 mg/ml CuSO4. The following strains were
compared: wild-type and UBP6 deletion cells (C),
disome V PGK1-GFP and disome V ubp6D cells
(D), disome XI PGK1-GFP and disome XI ubp6D
(E), wild-type and ubp6E256X truncation strains
(F), disome VIII PGK1-GFP and disome VIII
ubp6E256X cells, (G) and disome XI PGK1-GFP
and disome XI ubp6E256X cells (H). All strains
were grown in His+G418 medium.
See also Figure S6.a significant decrease in doubling time in disome V cells (4.2 ±
0.2 hr compared to 5.8 ± 0.8 hr; Figure 2D), but doubling times
were not as short as those of the evolved Dis V-14.1 strain
(3.8 ± 0.1; Figure 2D). Conversely, restoring UBP6 function to
the evolved Disome V-14.1 isolate reduced the proliferative
potential of these cells (Figure S5). We conclude that loss of
UBP6 function contributes to the increased proliferative abilities
of Dis V-14.1 cells but other genetic alterations found in this
strain also contribute to the increased proliferation rates of this
isolate.
Ubiquitin Depletion Is Not Responsible for the Increased
Proliferation Rates of Disomic Strains Lacking UBP6
Loss of Ubp6 function causes ubiquitin depletion. This leads to
cycloheximide sensitivity that can be suppressed by overex-
pression of ubiquitin (Hanna et al., 2003). Ubiquitin depletion
was also observed in disome V ubp6D cells (Figure 3A). To deter-
mine whether ubiquitin depletion was responsible for the
increased growth rate of disome V ubp6D cells, we examined
the consequences of increased ubiquitin expression. Disome V
and XI cells were cocultured with disome V ubp6D and disome
XI ubp6D cells, respectively. All strains carried a multicopy
plasmid expressing the ubiquitin-encoding gene, UBI4, under
the control of the copper inducible CUP1 promoter. Addition of
100 mM CuSO4 significantly increased the steady state levels
of free ubiquitin in all strains (Figure 3B). As expected, deletion
of UBP6 suppressed the subtly adverse effects of overexpres-
sion of ubiquitin in wild-type cells (Figures 3C and 3F). However,
high levels of ubiquitin did not abolish the growth rate improve-ments of disomic strains brought about by the inactivation of
UBP6 (Figures 3D and 3E; Figure S6A). Similar results were
obtained in disome VIII or XI strains harboring the ubp6E256X
truncation allele (Figures 3G and 3H; Figure S6B) and in compe-
tition experiments where only the UBP6 deleted strains overex-
pressed ubiquitin (Figure S6C). Our results indicate that low
levels of ubiquitin are not responsible for the improved fitness
of disomic strains lacking UBP6.
Aneuploid Yeast Cells Show an Increased Reliance
on Proteasomal Degradation for Survival
Ubp6 deubiquitinates substrates at the proteasome. This activity
serves two purposes: recycling of ubiquitin and rescue of protea-
somesubstrates fromdegradation.UBP6antagonizes theprotea-
somenotonly through itsdeubiquitinatingactivitybutalso through
a noncatalytic mechanism (Hanna et al., 2006; Peth et al., 2009).
To determine whether the catalytic or noncatalytic function of
Ubp6 was involved in modulating the fitness of disomic yeast
strains, we examined the consequences of replacing the catalytic
cysteine 110 with alanine (ubp6CA). Expression of the ubp6CA
allele did not affect the proliferative abilities of wild-type cells
(Figure 4A; Figure S7). In contrast, coculture of disome VIII, IX,
and XI cells with disomic cells carrying the ubp6CA allele showed
that strains harboring the catalytic dead version of the protein
quickly outcompete disomes carrying the wild-type UBP6 allele
(Figures 4B–4D). Our results demonstrate that Ubp6’s protease
activity antagonizes proliferation in several disomic yeast strains.
Inhibition of the catalytic activity of themammalian homolog of
Ubp6, Usp14, leads to accelerated degradation of a number ofCell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc. 77
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Figure 4. Disomic Strains Exhibit an
Increased Reliance on the Proteasome for
Survival
(A–D) The percentage of cells in cocultures of
strains carrying PGK1 fused to GFP (open
squares) and strains harboring a catalytic dead
version of UBP6 (ubp6CA, closed triangles) was
determined at the indicated times. The following
strains were compared: wild-type and ubp6CA
cells (A), disome VIII PGK1-GFP and disome VIII
upb6CA cells (B), disome IX PGK1-GFP and dis-
ome IX ubp6CA cells (C), and disome XI PGK1-
GFP and disome XI ubp6CA cells (D). All strains
were grown in His+G418 medium.
(E) Proliferation capabilities of WT, rpn6-ts,
parental disomes and disomes harboring the
rpn6-ts allele cells on YEPD medium at 25C,
30C, and 35C; 10-fold serial dilutions are shown.
See also Figure S7.proteins (Lee et al., 2010). These findings lead us to hypothesize
that increased proteasomal degradation of an unknown number
of proteins improves the fitness of disomic yeast strains. A
prediction of this hypothesis is that lowering of proteasomal
activity decreases the fitness of disomic yeast strains. This
appears to be the case. We previously showed that several
disomic strains exhibit increased sensitivity to the proteasome
inhibitor MG132 (Torres et al., 2007). Furthermore, a conditional
loss-of-function allele in the proteasome lid subunit Rpn6 encod-
ing gene (Ben-Aroya et al., 2008) was synthetic lethal with dis-
omy XII and disomy XIV (data not shown) and decreased the
proliferative abilities of almost all disomic strains tested
(Figure 4E). Finally, we found that the ubiquitin profile in strains
disomic for chromosome V, VIII, or XI resembles that of hypo-
morphic proteasome mutants: the levels of free ubiquitin are
slightly reduced (Figures 3A and 3B). Our results indicate that
proteasomal degradation is a rate-limiting pathway in most, or
perhaps all, disomic yeast strains.
Consequences of Chromosome V or XIII Disomy
on Cellular Protein Composition
To test the idea that increased protein degradation leads to
improved fitness of disomic strains, we examined the effects of78 Cell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc.deletion of UBP6 on the proteome of a
yeast strain whose fitness is improved
by the deletion of UBP6 (disome V) and
one that is not (disome XIII). To measure
relative protein abundance in disomic
and wild-type cells, we utilized stable
isotope labeling with amino acids in cell
culture (SILAC)-based quantitative mass
spectrometry (Extended Experimental
Procedures).
SILAC analysis of disome V and XIII
relative to wild-type cells revealed quanti-
tative information for 2953 proteins
(60.7% of all verified open reading frames
[ORFs]) and 3421 proteins (70.3% of allverified ORFs), respectively (Figures 5C and 5E; Table S5). The
analysis of the average abundance of proteins encoded by the
genes located on chromosome V and XIII demonstrated that
the average protein levels of chromosome V-located and chro-
mosome XIII-located genes were increased by 1.8-fold and
1.9-fold compared to the nonchromosome V or XIII encoded
proteins, respectively. This correlation is best seen when
proteins are sorted with respect to the chromosomal position
of their encoding genes (Figures 5C and 5E). To control for arti-
facts caused by growth in medium containing heavy lysine, we
performed a reverse labeling experiment, growing disome V cells
in light medium and wild-type cells in heavy medium and
compared the results of both analyses. We obtained quantitative
information on 2755 proteins, of which 2433 were detected in
both forward and reverse experiments (r2 = 0.59). Of these,
431 proteins show significant up- or downregulation in disome
V with high reproducibility (0.49 < log2 ratio < 0.49; r2 = 0.78,
n = 431; Extended Experimental Procedures).
An interesting additional aspect of the quantitative assess-
ment of the protein composition of the disomic strains is that
we are able to determinewhether there are proteins whose levels
do not increase according to gene copy number. A comprehen-
sive analysis of multiple disomic strains will be presented
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Figure 5. Quantification of the Proteome of
Disome V and Disome XIII Strains
The plots show the log2 ratio of the relative protein
abundance compared to wild-type. Protein levels
are shown in the order of the chromosomal loca-
tion of their encoding genes: wild-type/wild-type
ratios (A), Dubp6/wild-type ratios (B), disome
V/wild-type ratios (C), disome V Dubp6/wild-type
ratios (D), disome XIII/wild-type ratios (E), and dis-
ome XIII Dubp6/wild-type ratios (F). SD, standard
deviation; n, number of proteins quantified. See
also the Extended Experimental Procedures. The
number in the graphs shows the fold increase in
protein levels of proteins encoded by genes
located on the disomic chromosome relative to
the rest of the proteome.elsewhere, but several general conclusions are summarized
here. We previously analyzed the abundance of a small number
of proteins in disomic yeast strains and found that the levels of
several of these, especially subunits of macromolecular
complexes such as ribosome subunits, did not exhibit a coordi-
nate increase between gene copy number and protein levels
(Torres et al., 2007). Consistent with these observations, we
find that a considerable fraction of proteins located on chromo-
some V, 30 of a total 135 proteins detected in both disome V
experiments, were not upregulated according to gene copy
number. Ninety percent of the proteins that exhibit this property
are part of macromolecular complexes. Similar results were
obtained with disome XIII cells. Twenty-one percent of proteins
(65 of 312) did not show coregulation of protein levels with
gene copy number. Sixty-eight percent of these proteins func-
tion in largemacromolecular complexes. A discrepancy between
gene copy number and protein levels was most evident for
ribosomal subunits, but was also observed for subunits of
ribonucleotide reductase and the vacuolar ATPase. The enrich-
ment of protein complex subunits in the group of disome-
encoded proteins that does not show a coordinate upregulation
with gene copy number is of high statistical significance, when
compared to all proteins encoded by chromosome V or XIII
that are part of protein complexes (p value = 1.1 3 1010 for
disome V; p value = 3.8 3 103 for disome XIII). Analysis of
RNA and protein levels indicates that downregulation of gene
expression occurred either at the level of transcription (14 genesCell 143, 71–8in disome V and 22 genes in disome XIII)
or posttranscriptionally (16 genes in dis-
ome V and 43 genes in disome XIII).
Characterization of the feedback mecha-
nisms that ensure accurate stoichiome-
tries of these proteins will be an important
aspect of understanding the effects of
aneuploidy on cell physiology.
Deletion of UBP6 Attenuates
the Effects of Disomy V
on Cellular Protein Composition
Having established the effects of disomy
V on the yeast proteome, we next wishedto test the hypothesis that loss of UBP6 function improves the
fitness of aneuploid cells such as disome V cells by increasing
the degradation of proteins that are in excess in this strain. If
this was the case, the protein composition of disome V ubp6D
cells should bemore similar to wild-type cells than that of disome
V cells is to wild-type cells. This appears to be the case.
We obtained quantitative information on 2895 proteins for
disome V ubp6D cells (Figure 5D; Table S5) and on 3491 proteins
for cell lackingUBP6 (Figure 5B; Table S5). For the analysis of the
effects of UBP6 on protein composition, we only included
proteins for which quantitative information was obtained in all
four strains (2352 proteins). To determine whether deletion of
UBP6 attenuates the effects of disomy V on the intracellular
protein composition, we rank-ordered all of the proteins accord-
ing to their relative protein abundance levels in the strain disomic
for chromosome V and then asked how the expression of these
proteins changes in disome V cells lacking UBP6. To quantify
a potential attenuating effect, we created three bins: one that
encompasses all the proteins whose levels fall within one
standard deviation (SD) of the distribution (between 0.49 and
0.49, 1947 proteins; Figure 6A), one that encompasses proteins
whose relative abundance was low in disome V cells (log2 ratio <
0.49; 141 proteins Figure 6A), and one that encompasses
proteins whose relative abundance was high in the disome V
strain (log2 ratio > 0.49; 264 proteins; Figure 6A). We then calcu-
lated the mean of the protein abundance changes for each strain
for all three categories and compared them with each other.3, October 1, 2010 ª2010 Elsevier Inc. 79
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Figure 6. Loss of UBP6 Function Preferen-
tially Affects Proteins Overproduced in
Disome V and Disome XIII Cells Relative to
the Wild-Type
(A) Comparison of the means of the log2 ratios of
relative abundanceof proteins. Proteins are binned
basedon their relative levels in disomeVcells. Bin 1
(left bars) contains proteins whose levels are lower
than one SD of the mean (ratio < 0.49, n = 141).
Bin 2 (middle bars) contains proteins whose levels
fall within one SD of themean (0.49 < ratio < 0.49,
n=1947).Bin 3 (right bars) containsproteinswhose
levels are greater than one SD (ratio > 0.49, n =
264). Only proteins that were detected in all four
experiments were used for this analysis: disome
V compared to the wild-type (black bars), disome
V ubp6D compared to the wild-type (dark gray),
ubp6D compared to the wild-type (light gray), and
the wild-type/wild-type comparison (white bars)
are shown.
(B) RNA levels of the same genes analyzed in (A).
(C) The same analysis as in (A) was performed for
proteins encoded by genes located on chromo-
some V. The SD was that of the distribution of
chromosome V-encoded proteins. The bins are
as follows: ratio < 0.24, n = 16; 1.44 > ratio >
0.24, n = 105; and ratio > 1.44, n = 15. Nomencla-
ture is as in (A).
(D) RNA levels of the same proteins analyzed in (C).
(E) Comparison of the means of the log2 ratios of
relative abundanceof proteins. Proteins are binned
based on their relative levels in disome XIII cells as
described for disome XIII cells: bin 1 (left bars),
ratio <0.51, n = 112; bin 2 (middle bars),0.51 <
ratio <0.51, n =2,171; bin 3 (right bars), ratio >0.51,
n = 371. Only proteins that were detected in all four
experiments were used for this analysis: Disome
XIII compared to thewild-type (black bars), disome
XIII ubp6D compared to the wild-type (dark gray),
ubp6D compared to the wild-type (light gray), and
the wild-type/wild-type comparison (white bars)
are shown.
(F) RNA levels of the same proteins analyzed in (E).
(G) The same analysis as in (E) was performed for proteins encoded by genes located on chromosome XIII. The SDwas that of the distribution of chromosome XIII
encoded proteins. The bins are: ratio < 0.36, n = 16; 1.55 > ratio > 0.36, n = 190; and ratio > 1.55, n = 23. Nomenclature is as in (E).
(H) RNA levels of the same proteins analyzed in (G).
Error bars represent ± standard error of the mean. p, p value paired Student’s t test.The mean of proteins whose levels fall within one SD of
the distribution (0.49 and 0.49) was similar between wild-type,
ubp6D, disome V, and disome V ubp6D cells (disome V =0.02;
disome V ubp6D = 0.00; n = 1947; Figure 6A). In contrast,
deletion of UBP6 led to the attenuation in expression levels
of proteins whose relative abundances were low (log2 ratio <
0.49) in disome V cells (disome V = 0.81; disome V
ubp6D = 0.44; p value = 3 3 1019; n = 141; Figure 6A). The
effects of deletion of UBP6 were most dramatic among the
proteins with the highest relative expression levels in disome V
cells (ratio > 0.49). Whereas the mean of this bin was 0.96
for the disome V strain, it was 0.34 for disome V ubp6D cells
(n = 264; p value = 3 3 1035; Figure 6A).
The attenuating effects of deletion of UBP6 were also
observed for proteins encoded by genes located on chromo-
some V, although the effects were not as dramatic, which is80 Cell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc.most likely due to the limited number of proteins that could be
analyzed. The standard deviation we used for this analysis was
that of the distribution of proteins located on chromosome V,
which was 0.60. The average log2 expression level of chromo-
some V proteins was 0.84. The mean of proteins whose levels
fall within one SD of the distribution (0.24 and 1.44) was the
same between disome V and disome V ubp6D cells (disome
V = 0.84; disome V ubp6D = 0.84; n = 105; Figure 6C). For
proteins with low relative expression levels in disome V cells
(log2 ratios below 0.24), some attenuation was seen as a conse-
quence of UBP6 deletion (disome V = 0.25; disome V ubp6D =
0.16; n = 16; p value = 63 103; Figure 6C). The attenuation seen
for chromosome V proteins with the relative highest levels (ratios
above 1.44) was striking. Whereas the mean of this bin was 1.93
for disome V strain, it was 0.93 for disome V ubp6D cells (n = 15;
p value = 4 3 105; Figure 6C).
To determine whether transcriptional or posttranscriptional
mechanisms were responsible for the attenuating effects of
deletion of UBP6, we measured RNA levels in these strains.
Microarray analysis showed that deletion of UBP6 caused an
upregulation of transcription of proteins with low relative expres-
sion levels in disome V cells (Figure 6B). This finding indicates
that transcriptional effects are responsible for the attenuating
effects of UBP6 deletion on proteins underrepresented in
disome V cells. In contrast, decreased transcription was not
responsible for the attenuating effects of the UBP6 deletion on
proteins with high relative expression levels in disome V cells
(Figures 6B and 6D). These data show that inactivating UBP6
attenuates the effects of disomy V on the proteome in at least
two ways: (1) Inactivation of the ubiquitin protease promotes
the downregulation of proteins with high relative expression
levels in disome V cells by a posttranscriptional mechanism.
We presume that increased protein degradation is this mecha-
nism. (2) Deletion ofUBP6 promotes the upregulation of proteins
with low relative expression levels in disome V cells by increasing
their transcription, most likely by affecting the abundance of
proteins that regulate transcription of these genes.
Are the attenuating effects of deletingUBP6 specific to disome
V cells? Deletion ofUBP6 had a similar effect on the proteins with
high relative expression levels in disome XIII cells, even though
the proteins whose levels are increased in disome XIII cells
relative to wild-type are different than in disome V cells (Fig-
ures 6E and 6G; p value = 2 3 1022). Transcriptional profiling
indicated that this attenuating effect occurred at the posttran-
scriptional level (Figures 6F and 6H). In contrast to disome V
cells, deletion of UBP6 did not increase the abundance of
proteins with low relative expression levels in disome XIII cells
(Figure 6E).
Our results indicate that deletion of UBP6 causes attenuation
of proteins with high relative expression levels in disomic cells by
posttranscriptional mechanisms, most likely by increasing
protein degradation. We propose that in disome V cells this
effect on the protein composition increases growth rates,
because proteins that inhibit proliferation of disome V cells are
among the proteins whose levels are lowered by the deletion
of UBP6. This is not the case in disome XIII cells. We further
suggest that the attenuation of low expressed proteins, which
occurs in disome V cells but not disome XIII cells, contributes
to the differential effect of the UBP6 deletion on the two disomic
strains.
DISCUSSION
Aneuploidy-Tolerating Mutations
This study is to our knowledge the first to describe genetic
alterations that allow cells to tolerate the adverse effects of
aneuploidy. Our analysis of 13 evolved disomic strains identified
gross chromosomal rearrangements, chromosome loss, poly-
ploidization, and point mutations associated with increased
proliferation rates. Their characterization revealed a surprising
diversity in genetic alterations leading to improved growth rates.
We suspect that this is, to some extent, due to the experimental
design. The number of evolved strains that we analyzed was
small, and clones with improved growth properties were isolatedsoon after cultures experienced a decrease in doubling time.
Nevertheless, it appears that many different types of genetic
alterations can lead to improved growth in aneuploid yeast
strains. Conversely, most strains appeared to share a common
set of gene expression changes, perhaps indicating similar
phenotypic consequences.
Although our analysis is far from comprehensive, it was never-
theless striking that different types of genetic alterations pre-
dominate in different aneuploid strains. This observation raises
the possibility that different disomic yeast strains evolve by
different pathways. What determines this difference is not yet
clear, but perhaps different forms of genomic instability exist
among the disomes that lead to the favoring of one form of
evolution over another.
The genetic alterations we identified as causing aneuploidy
tolerance fall into two classes: (1) genetic changes unique to
a specific isolate or a disomic strain and (2) alterations found in
descendants of several disomic strains. Of special interest are
genetic alterations that affect the proliferation of multiple
aneuploidies. We identified three potential cases: a duplication
of 183 kb on chromosome XIII and mutations in VPS64 and
UBP6. The UBP6mutations indeed led to increased proliferation
in four different disomes. It will be interesting to determine
whether and how the other genetic alterations affect multiple
different disomes.
Modulation of the Ubiquitin-Proteasome Pathway
Affects Growth Rates in Aneuploid Yeast Cells
We have demonstrated that inactivation of UBP6 improves
proliferation of strains disomic for chromosome V, VIII, IX, and
XI. This effect was especially striking in –His+G418 medium,
where we believe the combination of frameshifts induced by
G418 and disomy places an especially high burden on the
proteasome. How does inactivation of UBP6 improve the fitness
of some aneuploid strains? Our analysis of UBP6 mutants
indicates that Ubp6’s proteasome-antagonizing function is
responsible for the increase in fitness of the aneuploid strains.
Quantitative proteomic approaches further indicate that deletion
of UBP6 reverts the overall protein composition of disome V and
XIII cells to a state that is more similar to that of wild-type cells.
This appears to bemediated by direct posttranscriptional effects
on high abundance proteins in disome V and XIII cells and
through indirect transcriptional effect on low-abundance
proteins in disome V cells.
Inactivation of UBP6 attenuates protein levels in both disome
V and XIII cells, so why does this improve fitness in disome V but
not disome XIII cells? Attenuation of downregulated proteins,
which we observe in disome V cells but not disome XIII cells,
could be responsible for the differential effects of the UBP6
deletion. Another not mutually exclusive possibility is that the
proteins that antagonize proliferation in disome V cells are
more efficiently degraded in the absence of UBP6 because
they are proteasome substrates. In contrast, proteins respon-
sible for decreasing the fitness of disome XIII cells are not. The
transcription factor Gcn4 illustrates this point. GO search termi-
nology revealed that genes encoding proteins involved in amino
acid metabolism were significantly enriched among the genes
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when UBP6 was deleted in these cells (49 out of 175, p value =
3 3 1033). Eighty-four of the 175 attenuated genes contain
binding sites for the Gcn4 transcription factor in their promoters
(http://rsat.ulb.ac.be/rsat/). The GCN4 gene is located on chro-
mosome V and the levels of the protein are increased in disome
V cells. We did not obtain quantitative information on Gcn4
protein levels from disome V ubp6D cells, but previous work
showed that Gcn4 degradation is accelerated in the absence
of UBP6 (Hanna et al., 2006). Deletion of GCN4 did not improve
the fitness of disome V cells (E.T., unpublished data), but
scenarios such as the one described for Gcn4 could be the
reason for why deletion of UBP6 affects the growth properties
of some aneuploids but not others.
The identification of mutations that accelerate protein degra-
dation as conferring aneuploidy tolerance and the observation
that several disomic cells harbored mutations in components
of the ubiquitin-proteasome system highlight the importance of
ubiquitin-mediated protein degradation in the survival of aneu-
ploid cells. Based on the observations that yeast strains carrying
additional yeast chromosomes show synthetic interactions with
mutations that affect proteasome function and exhibit an
increased sensitivity to conditions that interfere with protein
turnover and folding (and strains harboring non-yeast DNA do
not), we previously proposed that aneuploid cells are more
dependent on these pathways for survival than wild-type cells
(Torres et al., 2007). Excess proteins produced by the additional
chromosomes place an increased burden on the cell’s protein
quality control systems. The results presented here support
this idea. The quantitative assessment of the cellular protein
composition of disome V and XIII cells revealed that the addi-
tional chromosomes are indeed producing proteins. Although
the proteins that engage the protein degradation and folding
machineries will be different for each additional chromosome,
the necessity to degrade and fold excess proteins compromises
the cell’s ability to fold and degrade proteins whose excess
presence in the cell interferes with essential cellular processes.
Well-known examples of such proteins are a- and b-tubulin
(Anders et al., 2009; Katz et al., 1990) and histones (Gunjan
and Verreault, 2003; Meeks-Wagner and Hartwell, 1986). We
propose that in the absence of UBP6, clearance of excess
proteins is increased. This improves the fitness of strains, in
which the proteasome neutralizes the excess proteins that
impair growth. It is important to note that the increased reliance
on protein folding and degradation for survival and enhancement
of these pathways to improve fitness will not apply to the
condition of polyploidy. In polyploid cells, the entire genome is
duplicated and protein stoichiometries are not affected.
Aneuploidy-Tolerating Mutations— Implications
for Cancer
In humans, more than 90% of all solid tumors are aneuploid.
Whether and how aneuploidy promotes tumor formation remains
controversial (Holland and Cleveland, 2009; Schvartzman et al.,
2010). Irrespective of aneuploidy’s role in tumorigenesis, it is
clear from our studies that for tumor cells to acquire high
proliferative potential and to become malignant, they must over-
come the antiproliferative effects associated with aneuploidy.
Obtaining a comprehensive list of genes that modulate the82 Cell 143, 71–83, October 1, 2010 ª2010 Elsevier Inc.fitness of specific aneuploidies or the aneuploid state overall
could provide key insights into how cancer cells evolve to
escape the adverse effects of aneuploidy. Interestingly, 12 of
the 29 genes found mutated in the evolved yeast strains have
human homologs, some of which have been found to be upregu-
lated in tumors.
Finally, our results raise the possibility that aneuploid cancers
are under profound proteotoxic stress. This increased reliance of
aneuploid tumor cells on the ubiquitin-proteasome pathway
could provide the framework for the development of new cancer
therapeutics with a broad application spectrum and provide the
rational for the use of already approved proteasome inhibitors
such as Velcade in the treatment of aneuploid tumors in general.
EXPERIMENTAL PROCEDURES
Yeast Strains
All strains are derivatives ofW303 (A2587) and are listed in Table S6. TheUBP6
deletion, UBP6 truncation alleles, and PGK1-yEGFP-CaURA3 were created
with the PCR-based method described in Longtine et al. (1998). The
ubp6C110A allele was provided by D. Finley. The temperature-sensitive
rpn6-ts allele is described in Ben-Aroya et al. (2008). Disomy of all strains
was confirmed by CGH analysis (Torres et al., 2007) and is available at
http://puma.princeton.edu/ and in the Gene Expression Omnibus under
accession number GSE20464. Microarray gene expression data are also
deposited under this accession number.
Evolution of Aneuploid Yeast Cells
After inoculation from frozen stock directly into selective media, batch cultures
of wild-type and disomic strains were kept in exponential phase by manual
dilutions twice a day into fresh selective medium (His+G418) for 14 days
at room temperature. Optical densities varied between OD600nm of 0.1
and 1.0. Doubling times were calculated daily.
Competition Experiments
Approximately equal amounts of cells with andwithout PGK1-GFPweremixed
in selective medium at OD600nm = 0.2 and maintained in exponential growth
phase. Relative cell populations in the cultures were measured by flow cytom-
etry as cells containing PGK1-GFP exhibit three orders of magnitude higher
green fluorescence than the non-GFP cells.
Solexa Sequencing
DNA libraries were generated with the Illumina DNA preparation kit. A
summary of the number of reads, total number of bases sequenced, and
coverage are presented in Table S7. We used the assembled genome of
S288C (http://downloads.yeastgenome.org/) and aligned our wild-type strain
(W303, A2587) sequences with the Maq software package (http://maq.
sourceforge.net/). We found 1396 SNPs in W303 compared to S288C. Using
the assembled S288C genome and taking into account the SNPs found in
W303, we created a reference genome. The methods of SNP identification
are described in detail in the Extended Experimental Procedures.
Other techniques are described in the Extended Experimental Procedures.
ACCESSION NUMBERS
The Gene Expression Omnibus accession number for all the microarray data
including CGH and gene expression analysis reported in this paper is
GSE20464.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and seven tables and can be found with this article online at
doi:10.1016/j.cell.2010.08.038.
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